Centenary Nobel Prize in Physiology or Medicine for the cell cycle

Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer.

The European respiratory journal·2004

Hyperthermia-induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters.

The Journal of biological chemistry·2001

Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation.

Genes & development·2000

Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils.

Blood·1999

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.

The Journal of clinical investigation·1998

Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression.

Nature medicine·1997

Neutrophil extracellular traps in tumor progression: from mechanistic insights and regulatory factors to clinical detection and diagnosis.

Journal of molecular medicine (Berlin, Germany)·2026

SREBF2 promotes mitophagy and protects against ferroptosis via Cav-1-regulated PINK1/Parkin signaling in ischemic heart failure.

Journal of molecular medicine (Berlin, Germany)·2026

L-ICON3 Suppresses Endometriosis in a Murine Model.

Journal of molecular medicine (Berlin, Germany)·2026

The dual roles of lysine-specific demethylase 1 (KDM1A/LSD1) in the modulation of tumor immune microenvironment and its inhibitors in colorectal cancer.

Journal of molecular medicine (Berlin, Germany)·2026

Transforming growth factor-β1 promotes initiation of entheseal pathological bone formation via osteonectin induction in ankylosing spondylitis.

Journal of molecular medicine (Berlin, Germany)·2026

E-cigarette vaping is associated with pro-fibrotic gene expression in kidney and liver tissues.

Journal of molecular medicine (Berlin, Germany)·2026

Exercise interventions remodel the aging microenvironment to improve prognosis in older patients with cancer.

Frontiers in immunology·2026

Dynamic junction remodeling and transient vascular disruption during cancer cell extravasation across the blood-brain barrier.

Frontiers in cell and developmental biology·2026

RUNX3+ basal-like malignant cells: architects of an immunosuppressive microenvironment in bladder cancer: a comprehensive bioinformatics analysis of single-cell and spatial transcriptomics.

International journal of surgery (London, England)·2026

CPT1A through succinylation regulates the CTCF/LINC01503‒91aa feedback loop to promote gemcitabine resistance in pancreatic ductal adenocarcinoma.

Clinical and translational medicine·2026

CDK4/6 Inhibitors in the Management of Hormone Receptor-Positive (HR+)/Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Advanced Breast Cancer in Indonesia: Challenges, Opportunities, and Recommendations.

Asia-Pacific journal of clinical oncology·2026

Closing the gap in aging science: unlocking the potential of nanoparticles in senescence therapy.

Biogerontology·2026

Related Experiment Videos

Centenary Nobel Prize in Physiology or Medicine for the cell cycle

Related Concept Videos

Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer.

Hyperthermia-induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters.

Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation.

Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils.

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.

Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression.

Neutrophil extracellular traps in tumor progression: from mechanistic insights and regulatory factors to clinical detection and diagnosis.

SREBF2 promotes mitophagy and protects against ferroptosis via Cav-1-regulated PINK1/Parkin signaling in ischemic heart failure.

L-ICON3 Suppresses Endometriosis in a Murine Model.

The dual roles of lysine-specific demethylase 1 (KDM1A/LSD1) in the modulation of tumor immune microenvironment and its inhibitors in colorectal cancer.

Transforming growth factor-β1 promotes initiation of entheseal pathological bone formation via osteonectin induction in ankylosing spondylitis.

E-cigarette vaping is associated with pro-fibrotic gene expression in kidney and liver tissues.

Exercise interventions remodel the aging microenvironment to improve prognosis in older patients with cancer.

Dynamic junction remodeling and transient vascular disruption during cancer cell extravasation across the blood-brain barrier.

RUNX3+ basal-like malignant cells: architects of an immunosuppressive microenvironment in bladder cancer: a comprehensive bioinformatics analysis of single-cell and spatial transcriptomics.

CPT1A through succinylation regulates the CTCF/LINC01503‒91aa feedback loop to promote gemcitabine resistance in pancreatic ductal adenocarcinoma.

CDK4/6 Inhibitors in the Management of Hormone Receptor-Positive (HR+)/Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Advanced Breast Cancer in Indonesia: Challenges, Opportunities, and Recommendations.

Closing the gap in aging science: unlocking the potential of nanoparticles in senescence therapy.

Related Experiment Videos

Centenary Nobel Prize in Physiology or Medicine for the cell cycle

Related Concept Videos

Related Articles